This site is intended for healthcare professionals only

In association with the Cardiorenal Forum

Articles

  • Science and clinical management of cardiovascular–kidney–metabolic syndrome

  • Anticoagulant safety in people with advanced kidney disease and atrial fibrillation

  • Effect of intensive blood pressure control on long-term kidney outcomes

  • Chronic kidney disease markers as independent risk factors for incident atrial fibrillation

  • Uromodulin and risk for kidney failure

  • Man taking pill with water

    Dapagliflozin and cardiovascular risks with worsening renal function

  • Rack of blood sample tubes

    Cardiorenal biomarkers in the CREDENCE trial

  • Inhibition of the renin–angiotensin–aldosterone system in early chronic kidney disease: do we know as much as we think we do?

  • Benefits and harms of RAAS inhibition in adults with early chronic kidney disease

alt

For the latest news and articles
Sign up to Renal Review newsletters

Subscribe